

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.56051768 |
| 2 | plasma membrane repair (GO:0001778) | 8.31682465 |
| 3 | actin filament-based movement (GO:0030048) | 8.27705533 |
| 4 | * sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.02881781 |
| 5 | * skeletal muscle fiber development (GO:0048741) | 7.55058095 |
| 6 | striated muscle contraction (GO:0006941) | 6.97405643 |
| 7 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.65867990 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.60054229 |
| 9 | * myotube cell development (GO:0014904) | 6.41716619 |
| 10 | skeletal muscle tissue regeneration (GO:0043403) | 6.38082499 |
| 11 | sarcomere organization (GO:0045214) | 6.20201135 |
| 12 | response to inactivity (GO:0014854) | 6.15749917 |
| 13 | striated muscle atrophy (GO:0014891) | 6.12206339 |
| 14 | glycogen catabolic process (GO:0005980) | 5.84589145 |
| 15 | creatine metabolic process (GO:0006600) | 5.76258917 |
| 16 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.71665851 |
| 17 | * muscle contraction (GO:0006936) | 5.69590722 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.69180741 |
| 19 | myofibril assembly (GO:0030239) | 5.61420544 |
| 20 | regulation of cell communication by electrical coupling (GO:0010649) | 5.57721595 |
| 21 | response to muscle activity (GO:0014850) | 5.57215490 |
| 22 | glucan catabolic process (GO:0009251) | 5.45664603 |
| 23 | muscle atrophy (GO:0014889) | 5.39553602 |
| 24 | cytidine metabolic process (GO:0046087) | 5.38189149 |
| 25 | cytidine catabolic process (GO:0006216) | 5.38189149 |
| 26 | cytidine deamination (GO:0009972) | 5.38189149 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.36157123 |
| 28 | striated muscle adaptation (GO:0014888) | 5.23158634 |
| 29 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.15869981 |
| 30 | carnitine shuttle (GO:0006853) | 5.14079259 |
| 31 | cellular polysaccharide catabolic process (GO:0044247) | 5.10541890 |
| 32 | * muscle system process (GO:0003012) | 5.06543155 |
| 33 | purine nucleotide salvage (GO:0032261) | 5.04610806 |
| 34 | polysaccharide catabolic process (GO:0000272) | 4.91357043 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 4.76976344 |
| 36 | regulation of actin filament-based movement (GO:1903115) | 4.72273164 |
| 37 | glucan biosynthetic process (GO:0009250) | 4.58411909 |
| 38 | glycogen biosynthetic process (GO:0005978) | 4.58411909 |
| 39 | myoblast fusion (GO:0007520) | 4.56164569 |
| 40 | actomyosin structure organization (GO:0031032) | 4.55525552 |
| 41 | striated muscle hypertrophy (GO:0014897) | 4.54177523 |
| 42 | * muscle fiber development (GO:0048747) | 4.53151499 |
| 43 | neuromuscular synaptic transmission (GO:0007274) | 4.48956738 |
| 44 | neuronal action potential propagation (GO:0019227) | 4.42898261 |
| 45 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.42486303 |
| 46 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.41332632 |
| 47 | NADH metabolic process (GO:0006734) | 4.35038701 |
| 48 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.34974671 |
| 49 | muscle organ development (GO:0007517) | 4.30102437 |
| 50 | IMP metabolic process (GO:0046040) | 4.27055603 |
| 51 | fatty acid transmembrane transport (GO:1902001) | 4.26929428 |
| 52 | muscle cell cellular homeostasis (GO:0046716) | 4.26926559 |
| 53 | muscle adaptation (GO:0043500) | 4.24755008 |
| 54 | muscle structure development (GO:0061061) | 4.22988066 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.11459192 |
| 56 | myotube differentiation (GO:0014902) | 4.10664786 |
| 57 | muscle hypertrophy (GO:0014896) | 4.09112278 |
| 58 | syncytium formation by plasma membrane fusion (GO:0000768) | 4.08328499 |
| 59 | positive regulation of myotube differentiation (GO:0010831) | 4.07193513 |
| 60 | skeletal muscle tissue development (GO:0007519) | 4.03613528 |
| 61 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.99798996 |
| 62 | syncytium formation (GO:0006949) | 3.99792101 |
| 63 | glycogen metabolic process (GO:0005977) | 3.98296277 |
| 64 | negative regulation of muscle hypertrophy (GO:0014741) | 3.95961849 |
| 65 | fructose metabolic process (GO:0006000) | 3.93375646 |
| 66 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.92123978 |
| 67 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.90614958 |
| 68 | glucan metabolic process (GO:0044042) | 3.89806557 |
| 69 | cellular glucan metabolic process (GO:0006073) | 3.89806557 |
| 70 | cardiac muscle contraction (GO:0060048) | 3.87188075 |
| 71 | muscle tissue morphogenesis (GO:0060415) | 3.76205405 |
| 72 | response to activity (GO:0014823) | 3.76052682 |
| 73 | carnitine transmembrane transport (GO:1902603) | 3.74709784 |
| 74 | muscle cell fate commitment (GO:0042693) | 3.73577013 |
| 75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.73375175 |
| 76 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.73375175 |
| 77 | regulation of relaxation of muscle (GO:1901077) | 3.70078139 |
| 78 | muscle organ morphogenesis (GO:0048644) | 3.70057728 |
| 79 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.65793067 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63233374 |
| 81 | regulation of coenzyme metabolic process (GO:0051196) | 3.58391316 |
| 82 | regulation of cofactor metabolic process (GO:0051193) | 3.58391316 |
| 83 | adult heart development (GO:0007512) | 3.57495419 |
| 84 | cardiac muscle adaptation (GO:0014887) | 3.57222548 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.57222548 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 3.57222548 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.57084519 |
| 88 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.53203202 |
| 89 | neuromuscular junction development (GO:0007528) | 3.52556980 |
| 90 | positive regulation of myoblast differentiation (GO:0045663) | 3.50562031 |
| 91 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.48292237 |
| 92 | striated muscle tissue development (GO:0014706) | 3.47112597 |
| 93 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.46689137 |
| 94 | gluconeogenesis (GO:0006094) | 3.46614235 |
| 95 | negative regulation of muscle contraction (GO:0045932) | 3.44534707 |
| 96 | cardiac muscle cell development (GO:0055013) | 3.42439311 |
| 97 | * striated muscle cell development (GO:0055002) | 3.38326875 |
| 98 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.38176376 |
| 99 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.38176376 |
| 100 | carnitine transport (GO:0015879) | 3.38016310 |
| 101 | amino-acid betaine transport (GO:0015838) | 3.38016310 |
| 102 | regulation of striated muscle contraction (GO:0006942) | 3.36650728 |
| 103 | regulation of sarcomere organization (GO:0060297) | 3.34873033 |
| 104 | regulation of myoblast differentiation (GO:0045661) | 3.31645687 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29697439 |
| 106 | regulation of myotube differentiation (GO:0010830) | 3.24844441 |
| 107 | regulation of muscle system process (GO:0090257) | 3.24237981 |
| 108 | cellular response to dexamethasone stimulus (GO:0071549) | 3.22649336 |
| 109 | positive regulation of cation channel activity (GO:2001259) | 3.22346201 |
| 110 | relaxation of muscle (GO:0090075) | 3.20472725 |
| 111 | cardiac cell development (GO:0055006) | 3.19469356 |
| 112 | regulation of membrane repolarization (GO:0060306) | 3.18728736 |
| 113 | IMP biosynthetic process (GO:0006188) | 3.17926141 |
| 114 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15992017 |
| 115 | cellular carbohydrate catabolic process (GO:0044275) | 3.15004914 |
| 116 | membrane depolarization during action potential (GO:0086010) | 3.13365639 |
| 117 | regulation of skeletal muscle fiber development (GO:0048742) | 3.11042976 |
| 118 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.08704971 |
| 119 | cardiac myofibril assembly (GO:0055003) | 3.03132131 |
| 120 | response to dexamethasone (GO:0071548) | 2.96402604 |
| 121 | regulation of sulfur metabolic process (GO:0042762) | 2.94136625 |
| 122 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.93901626 |
| 123 | skeletal muscle cell differentiation (GO:0035914) | 2.93580600 |
| 124 | calcium ion import (GO:0070509) | 2.90719651 |
| 125 | muscle filament sliding (GO:0030049) | 13.3821453 |
| 126 | actin-myosin filament sliding (GO:0033275) | 13.3821453 |
| 127 | regulation of skeletal muscle contraction (GO:0014819) | 12.3263618 |
| 128 | skeletal muscle contraction (GO:0003009) | 12.0033107 |
| 129 | actin-mediated cell contraction (GO:0070252) | 10.9535085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.60452044 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.10231273 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.61287011 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.09714932 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.07303783 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.51535463 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14138083 |
| 8 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.09063325 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08926374 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07769056 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07733319 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04725853 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.02198021 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.02198021 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94911474 |
| 16 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.83700627 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81256370 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.75042479 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74805239 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72632391 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71366858 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63597269 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62417104 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59643969 |
| 25 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.59507290 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55065227 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.53266649 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.53266649 |
| 29 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49401944 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48922064 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.44990500 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44800545 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44160232 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43780783 |
| 35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41283530 |
| 36 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.40500440 |
| 37 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39485490 |
| 38 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.38660391 |
| 39 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.38460975 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38074929 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37282153 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37260517 |
| 43 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.36799935 |
| 44 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.36179480 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35427998 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34581716 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33680477 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33565613 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30474383 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27963676 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22914491 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22214552 |
| 53 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20985667 |
| 54 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.20041891 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16835942 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16396879 |
| 57 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.16395060 |
| 58 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16336887 |
| 59 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16157470 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15736409 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14563274 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13990944 |
| 63 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.11206497 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09993303 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09679045 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08103989 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06884010 |
| 68 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05735894 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04440890 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04094044 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03792681 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03341401 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02544497 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02017062 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01886890 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01852214 |
| 77 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00849126 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00068078 |
| 79 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.99958613 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99394813 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98853801 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98600884 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97736353 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97610645 |
| 85 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.97603348 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96955838 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96775967 |
| 88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96291184 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95984599 |
| 90 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.94926895 |
| 91 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.94706341 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93242227 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93207938 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93164545 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92093750 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91477338 |
| 97 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91158148 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90914337 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90618788 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90562160 |
| 101 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.90435521 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89929240 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89832652 |
| 104 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89211396 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89161958 |
| 106 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88792508 |
| 107 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.88792508 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88729029 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88029379 |
| 110 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87857660 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85574119 |
| 112 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.84781841 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 0.84627050 |
| 114 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84220823 |
| 115 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84115488 |
| 116 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82547705 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82028313 |
| 118 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81892398 |
| 119 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81769973 |
| 120 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81747424 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81717712 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81660898 |
| 123 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80953678 |
| 124 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80838123 |
| 125 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80366704 |
| 126 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.79881914 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79846691 |
| 128 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.79736390 |
| 129 | * AR_19668381_ChIP-Seq_PC3_Human | 0.79727307 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79552504 |
| 131 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.78926381 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77920600 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77471647 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77471647 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76901508 |
| 136 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76748188 |
| 137 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.76626032 |
| 138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.74406899 |
| 139 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74137866 |
| 140 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.71943184 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.71692391 |
| 142 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71631103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.05390379 |
| 2 | MP0000751_myopathy | 6.18152105 |
| 3 | MP0003646_muscle_fatigue | 6.11485506 |
| 4 | * MP0000749_muscle_degeneration | 5.94058507 |
| 5 | MP0000747_muscle_weakness | 4.81269794 |
| 6 | * MP0002106_abnormal_muscle_physiology | 4.22706679 |
| 7 | * MP0000759_abnormal_skeletal_muscle | 3.92896622 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.84983847 |
| 9 | MP0002269_muscular_atrophy | 3.63460929 |
| 10 | * MP0005369_muscle_phenotype | 3.55389885 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.48491955 |
| 12 | * MP0004087_abnormal_muscle_fiber | 3.45276832 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.37510369 |
| 14 | MP0004130_abnormal_muscle_cell | 3.08734851 |
| 15 | * MP0005620_abnormal_muscle_contractility | 2.98887643 |
| 16 | MP0004233_abnormal_muscle_weight | 2.69501458 |
| 17 | * MP0000733_abnormal_muscle_development | 2.32147783 |
| 18 | MP0002108_abnormal_muscle_morphology | 2.23454730 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.20060334 |
| 20 | MP0005330_cardiomyopathy | 1.84463651 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.71098150 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.58464245 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.55374869 |
| 24 | MP0005275_abnormal_skin_tensile | 1.38255348 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.37558015 |
| 26 | MP0001661_extended_life_span | 1.36281687 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.34711409 |
| 28 | MP0004484_altered_response_of | 1.31528747 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.29317120 |
| 30 | MP0002972_abnormal_cardiac_muscle | 1.24381735 |
| 31 | MP0004859_abnormal_synaptic_plasticity | 1.16438335 |
| 32 | MP0010630_abnormal_cardiac_muscle | 1.13718916 |
| 33 | * MP0002971_abnormal_brown_adipose | 1.08049306 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.07846942 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.06881609 |
| 36 | MP0002234_abnormal_pharynx_morphology | 0.99743359 |
| 37 | MP0005266_abnormal_metabolism | 0.95241677 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 0.94119148 |
| 39 | MP0002822_catalepsy | 0.92580428 |
| 40 | MP0001299_abnormal_eye_distance/ | 0.89701117 |
| 41 | MP0004134_abnormal_chest_morphology | 0.86477005 |
| 42 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85207168 |
| 43 | MP0008569_lethality_at_weaning | 0.85075444 |
| 44 | MP0000762_abnormal_tongue_morphology | 0.81884941 |
| 45 | MP0003137_abnormal_impulse_conducting | 0.81592968 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 0.80675927 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 0.77338617 |
| 48 | MP0005385_cardiovascular_system_phenoty | 0.77338617 |
| 49 | MP0008961_abnormal_basal_metabolism | 0.74580242 |
| 50 | MP0002796_impaired_skin_barrier | 0.73478482 |
| 51 | MP0003828_pulmonary_edema | 0.70096429 |
| 52 | MP0009250_abnormal_appendicular_skeleto | 0.69440097 |
| 53 | MP0000003_abnormal_adipose_tissue | 0.68810618 |
| 54 | MP0000372_irregular_coat_pigmentation | 0.68493343 |
| 55 | MP0000579_abnormal_nail_morphology | 0.61090851 |
| 56 | * MP0004270_analgesia | 0.61012728 |
| 57 | MP0004043_abnormal_pH_regulation | 0.60053494 |
| 58 | MP0003045_fibrosis | 0.58170030 |
| 59 | MP0004147_increased_porphyrin_level | 0.58159533 |
| 60 | MP0005670_abnormal_white_adipose | 0.55753480 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.53435005 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 0.53194827 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.52853186 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.52525908 |
| 65 | MP0005334_abnormal_fat_pad | 0.51949747 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 0.51352726 |
| 67 | MP0005423_abnormal_somatic_nervous | 0.50814671 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 0.47393409 |
| 69 | MP0004142_abnormal_muscle_tone | 0.46819680 |
| 70 | MP0002638_abnormal_pupillary_reflex | 0.44134794 |
| 71 | MP0001440_abnormal_grooming_behavior | 0.44123465 |
| 72 | MP0005503_abnormal_tendon_morphology | 0.43822609 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 0.43739525 |
| 74 | * MP0000266_abnormal_heart_morphology | 0.43026189 |
| 75 | MP0010030_abnormal_orbit_morphology | 0.42203566 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.42129209 |
| 77 | MP0004510_myositis | 0.42115235 |
| 78 | * MP0005452_abnormal_adipose_tissue | 0.39872692 |
| 79 | * MP0002114_abnormal_axial_skeleton | 0.39742008 |
| 80 | MP0001849_ear_inflammation | 0.39394151 |
| 81 | MP0000383_abnormal_hair_follicle | 0.38788141 |
| 82 | MP0002128_abnormal_blood_circulation | 0.38176415 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.37452275 |
| 84 | MP0006138_congestive_heart_failure | 0.35840717 |
| 85 | MP0003959_abnormal_lean_body | 0.35653863 |
| 86 | MP0005501_abnormal_skin_physiology | 0.35346752 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.35297428 |
| 88 | * MP0002066_abnormal_motor_capabilities/c | 0.34970985 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.34423907 |
| 90 | MP0008438_abnormal_cutaneous_collagen | 0.33963790 |
| 91 | MP0004085_abnormal_heartbeat | 0.33655044 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.33067771 |
| 93 | MP0005083_abnormal_biliary_tract | 0.33018912 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.31179957 |
| 95 | MP0008770_decreased_survivor_rate | 0.31094278 |
| 96 | MP0000343_altered_response_to | 0.30839597 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.30712946 |
| 98 | MP0003879_abnormal_hair_cell | 0.30195577 |
| 99 | MP0000427_abnormal_hair_cycle | 0.28145568 |
| 100 | MP0002067_abnormal_sensory_capabilities | 0.27648095 |
| 101 | MP0009115_abnormal_fat_cell | 0.27297681 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.26619586 |
| 103 | * MP0003948_abnormal_gas_homeostasis | 0.26366586 |
| 104 | MP0005165_increased_susceptibility_to | 0.25972627 |
| 105 | * MP0001943_abnormal_respiration | 0.25767722 |
| 106 | MP0002249_abnormal_larynx_morphology | 0.24518960 |
| 107 | MP0004858_abnormal_nervous_system | 0.24467906 |
| 108 | MP0005166_decreased_susceptibility_to | 0.23722825 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.23229132 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.21963378 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.21581701 |
| 112 | MP0005451_abnormal_body_composition | 0.20563691 |
| 113 | MP0009046_muscle_twitch | 0.20449985 |
| 114 | MP0002063_abnormal_learning/memory/cond | 0.20186276 |
| 115 | MP0002060_abnormal_skin_morphology | 0.19739158 |
| 116 | MP0002184_abnormal_innervation | 0.19489071 |
| 117 | MP0005187_abnormal_penis_morphology | 0.16427803 |
| 118 | * MP0002734_abnormal_mechanical_nocicepti | 0.16189320 |
| 119 | MP0005332_abnormal_amino_acid | 0.15248620 |
| 120 | * MP0009672_abnormal_birth_weight | 0.12630585 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.12565769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.68937671 |
| 2 | * Nemaline bodies (HP:0003798) | 8.84241678 |
| 3 | Distal arthrogryposis (HP:0005684) | 8.30647028 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.44589598 |
| 5 | * Type 1 muscle fiber predominance (HP:0003803) | 7.11835889 |
| 6 | * Exercise-induced myalgia (HP:0003738) | 7.00024078 |
| 7 | Round ear (HP:0100830) | 6.93226452 |
| 8 | Ulnar deviation of the wrist (HP:0003049) | 6.68288152 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.59731251 |
| 10 | * Myopathic facies (HP:0002058) | 6.03942734 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 5.96819109 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.82646196 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.41430819 |
| 14 | Deformed tarsal bones (HP:0008119) | 5.39275457 |
| 15 | Absent phalangeal crease (HP:0006109) | 5.30837051 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.93415255 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.73371720 |
| 18 | Abnormal finger flexion creases (HP:0006143) | 4.45406678 |
| 19 | Muscle stiffness (HP:0003552) | 4.41935858 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.27156849 |
| 21 | Myotonia (HP:0002486) | 4.06966058 |
| 22 | * Difficulty running (HP:0009046) | 4.05801481 |
| 23 | Neck muscle weakness (HP:0000467) | 3.91883617 |
| 24 | * Myoglobinuria (HP:0002913) | 3.79493335 |
| 25 | Difficulty climbing stairs (HP:0003551) | 3.69445031 |
| 26 | Frequent falls (HP:0002359) | 3.60986067 |
| 27 | Abnormality of the calcaneus (HP:0008364) | 3.50234558 |
| 28 | * Malignant hyperthermia (HP:0002047) | 3.48243402 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.44382945 |
| 30 | Fetal akinesia sequence (HP:0001989) | 3.40479788 |
| 31 | Subaortic stenosis (HP:0001682) | 3.39296370 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.39296370 |
| 33 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 3.34448193 |
| 34 | Abnormality of the neuromuscular junction (HP:0003398) | 3.30646420 |
| 35 | Fatigable weakness (HP:0003473) | 3.30646420 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 3.30211751 |
| 37 | Pelvic girdle muscle weakness (HP:0003749) | 3.28032195 |
| 38 | Slender build (HP:0001533) | 3.20364387 |
| 39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.17131861 |
| 40 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.17131861 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.15221515 |
| 42 | * Rhabdomyolysis (HP:0003201) | 2.94480580 |
| 43 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.88774397 |
| 44 | Bundle branch block (HP:0011710) | 2.84112659 |
| 45 | Bulbar palsy (HP:0001283) | 2.83783343 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.78479678 |
| 47 | * Increased connective tissue (HP:0009025) | 2.68396374 |
| 48 | Weak cry (HP:0001612) | 2.62595055 |
| 49 | * Increased variability in muscle fiber diameter (HP:0003557) | 2.62176098 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.62149420 |
| 51 | Sudden death (HP:0001699) | 2.61014211 |
| 52 | Gowers sign (HP:0003391) | 2.55710780 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.54266666 |
| 54 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50887909 |
| 55 | Spinal rigidity (HP:0003306) | 2.46858515 |
| 56 | Distal lower limb amyotrophy (HP:0008944) | 2.46452843 |
| 57 | Paralysis (HP:0003470) | 2.44268884 |
| 58 | Metatarsus adductus (HP:0001840) | 2.43864000 |
| 59 | Proximal amyotrophy (HP:0007126) | 2.40635331 |
| 60 | Ulnar deviation of finger (HP:0009465) | 2.38377132 |
| 61 | Scapular winging (HP:0003691) | 2.37395957 |
| 62 | Facial diplegia (HP:0001349) | 2.32773177 |
| 63 | Dilated cardiomyopathy (HP:0001644) | 2.32601744 |
| 64 | Hip contracture (HP:0003273) | 2.26391478 |
| 65 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.26214600 |
| 66 | Limb-girdle muscle weakness (HP:0003325) | 2.24925833 |
| 67 | Hypoplastic ischia (HP:0003175) | 2.21870652 |
| 68 | Lipoatrophy (HP:0100578) | 2.09620635 |
| 69 | Limb-girdle muscle atrophy (HP:0003797) | 2.08884683 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.07788205 |
| 71 | Waddling gait (HP:0002515) | 2.07500285 |
| 72 | * Generalized muscle weakness (HP:0003324) | 2.01824174 |
| 73 | * Muscle fiber inclusion bodies (HP:0100299) | 10.1879625 |
| 74 | Progressive muscle weakness (HP:0003323) | 1.99911714 |
| 75 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.94681982 |
| 76 | Abnormality of the ischium (HP:0003174) | 1.92241534 |
| 77 | Lower limb amyotrophy (HP:0007210) | 1.91536513 |
| 78 | Achilles tendon contracture (HP:0001771) | 1.89258763 |
| 79 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.87729844 |
| 80 | Tarsal synostosis (HP:0008368) | 1.86791321 |
| 81 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.85860590 |
| 82 | Long clavicles (HP:0000890) | 1.85323930 |
| 83 | Muscle fiber atrophy (HP:0100295) | 1.85056972 |
| 84 | * Muscular dystrophy (HP:0003560) | 1.83911470 |
| 85 | Popliteal pterygium (HP:0009756) | 1.83245302 |
| 86 | Heart block (HP:0012722) | 1.82097401 |
| 87 | * Hyperkalemia (HP:0002153) | 1.76560052 |
| 88 | Abnormal atrioventricular conduction (HP:0005150) | 1.71226434 |
| 89 | Synostosis involving bones of the feet (HP:0009140) | 1.69403519 |
| 90 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.69403519 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.69087117 |
| 92 | Adducted thumb (HP:0001181) | 1.67563937 |
| 93 | Easy fatigability (HP:0003388) | 1.59584580 |
| 94 | Limited hip movement (HP:0008800) | 1.57376689 |
| 95 | Short palpebral fissure (HP:0012745) | 1.56150327 |
| 96 | Increased density of long bones (HP:0006392) | 1.55267289 |
| 97 | Exercise intolerance (HP:0003546) | 1.53492136 |
| 98 | Aplasia of the musculature (HP:0100854) | 1.52839319 |
| 99 | Ventricular tachycardia (HP:0004756) | 1.49378079 |
| 100 | Oligomenorrhea (HP:0000876) | 1.47621545 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 1.47517541 |
| 102 | Ventricular arrhythmia (HP:0004308) | 1.47019830 |
| 103 | Abnormality of placental membranes (HP:0011409) | 1.46391661 |
| 104 | Amniotic constriction ring (HP:0009775) | 1.46391661 |
| 105 | Steppage gait (HP:0003376) | 1.44922547 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.44808948 |
| 107 | Breech presentation (HP:0001623) | 1.43852222 |
| 108 | Cholelithiasis (HP:0001081) | 1.41085715 |
| 109 | Toxemia of pregnancy (HP:0100603) | 1.38976207 |
| 110 | Webbed neck (HP:0000465) | 1.38495572 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 1.36758195 |
| 112 | Diaphragmatic weakness (HP:0009113) | 1.34744891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.04372579 |
| 2 | TTN | 5.85976767 |
| 3 | PHKG1 | 5.14480365 |
| 4 | PHKG2 | 5.14480365 |
| 5 | PIK3CG | 4.36782409 |
| 6 | NME1 | 4.26792550 |
| 7 | MAP2K3 | 2.58836494 |
| 8 | MAP3K7 | 2.21839177 |
| 9 | NEK1 | 2.13690023 |
| 10 | PINK1 | 2.06248490 |
| 11 | TRIB3 | 1.95078539 |
| 12 | MUSK | 1.93643568 |
| 13 | DMPK | 1.70556175 |
| 14 | MAP2K4 | 1.66479407 |
| 15 | PDK3 | 1.66256292 |
| 16 | PDK4 | 1.66256292 |
| 17 | MAPK12 | 1.59570876 |
| 18 | PIK3CA | 1.34211704 |
| 19 | MAP2K6 | 1.31175944 |
| 20 | MARK1 | 1.18100413 |
| 21 | CCNB1 | 1.15017552 |
| 22 | TAOK2 | 1.10294548 |
| 23 | PDK2 | 1.08834284 |
| 24 | BCKDK | 0.97690622 |
| 25 | NTRK3 | 0.92253054 |
| 26 | PRKAA2 | 0.83762446 |
| 27 | MAPKAPK3 | 0.81676751 |
| 28 | MAP3K13 | 0.77736581 |
| 29 | PRKAA1 | 0.74850467 |
| 30 | MAP3K3 | 0.71775540 |
| 31 | RIPK1 | 0.69623788 |
| 32 | ZAK | 0.69618490 |
| 33 | AKT2 | 0.68811761 |
| 34 | MOS | 0.68803551 |
| 35 | TAOK1 | 0.67052747 |
| 36 | CAMK4 | 0.63407955 |
| 37 | ERBB3 | 0.61991082 |
| 38 | PKN2 | 0.58114069 |
| 39 | EPHB1 | 0.57532308 |
| 40 | MAPK11 | 0.56517153 |
| 41 | TRPM7 | 0.55367920 |
| 42 | SIK1 | 0.54430632 |
| 43 | EPHA4 | 0.51794312 |
| 44 | NEK9 | 0.51094161 |
| 45 | SGK1 | 0.49151195 |
| 46 | CAMK1 | 0.47893250 |
| 47 | TIE1 | 0.45601114 |
| 48 | * CAMK2G | 0.45257053 |
| 49 | KSR2 | 0.43467024 |
| 50 | MAP3K6 | 0.42110997 |
| 51 | SGK2 | 0.42109278 |
| 52 | MAP3K11 | 0.41835804 |
| 53 | MAP2K1 | 0.39021022 |
| 54 | STK24 | 0.34454042 |
| 55 | MAP3K5 | 0.32330961 |
| 56 | RPS6KB1 | 0.32266569 |
| 57 | ILK | 0.31653763 |
| 58 | PAK6 | 0.31134340 |
| 59 | PRKACB | 0.30218149 |
| 60 | * RPS6KA3 | 0.28877583 |
| 61 | MAP3K4 | 0.27324939 |
| 62 | PTK6 | 0.27149385 |
| 63 | PRPF4B | 0.26746298 |
| 64 | MAPK7 | 0.25874640 |
| 65 | MAP3K1 | 0.25869300 |
| 66 | EEF2K | 0.25614879 |
| 67 | KSR1 | 0.25181258 |
| 68 | DAPK2 | 0.24557870 |
| 69 | LIMK1 | 0.23773769 |
| 70 | PKN1 | 0.23495602 |
| 71 | PDPK1 | 0.23392324 |
| 72 | SGK494 | 0.22667313 |
| 73 | SGK223 | 0.22667313 |
| 74 | FER | 0.21855561 |
| 75 | ROCK1 | 0.21515878 |
| 76 | TBK1 | 0.21056204 |
| 77 | TNIK | 0.20886962 |
| 78 | BMX | 0.20812211 |
| 79 | TGFBR2 | 0.20611561 |
| 80 | CDK19 | 0.20135421 |
| 81 | DDR2 | 0.20011051 |
| 82 | MARK2 | 0.19895711 |
| 83 | PDK1 | 0.19268341 |
| 84 | ICK | 0.18323753 |
| 85 | MAP3K9 | 0.17823085 |
| 86 | * PRKACA | 0.17784801 |
| 87 | RPS6KB2 | 0.17732091 |
| 88 | EPHA3 | 0.17725134 |
| 89 | ARAF | 0.17160102 |
| 90 | SGK3 | 0.16728091 |
| 91 | STK11 | 0.15933396 |
| 92 | CAMK1G | 0.15916243 |
| 93 | LATS2 | 0.15450356 |
| 94 | * PRKG1 | 0.14926962 |
| 95 | FGFR1 | 0.14763136 |
| 96 | LATS1 | 0.13476139 |
| 97 | NLK | 0.13345744 |
| 98 | MAPK10 | 0.13292764 |
| 99 | PTK2B | 0.13072039 |
| 100 | CAMK2A | 0.12668797 |
| 101 | STK38 | 0.12565605 |
| 102 | MAPK4 | 0.12060184 |
| 103 | PRKD1 | 0.11770659 |
| 104 | MAP3K10 | 0.10640586 |
| 105 | CAMK2D | 0.10282705 |
| 106 | FGFR3 | 0.10068536 |
| 107 | MAPK8 | 0.10057026 |
| 108 | PRKD3 | 0.09685131 |
| 109 | RAF1 | 0.09549547 |
| 110 | CDK5 | 0.09073568 |
| 111 | MAPK13 | 0.08785420 |
| 112 | RPS6KL1 | 0.08430762 |
| 113 | RPS6KC1 | 0.08430762 |
| 114 | MARK3 | 0.08320607 |
| 115 | ROCK2 | 0.08012728 |
| 116 | ZAP70 | 0.07548470 |
| 117 | INSRR | 0.06909953 |
| 118 | GSK3B | 0.05993401 |
| 119 | CDC42BPA | 0.05875903 |
| 120 | DYRK1B | 0.05817799 |
| 121 | MTOR | 0.05761571 |
| 122 | PRKCH | 0.05719303 |
| 123 | RPS6KA1 | 0.05500028 |
| 124 | RPS6KA2 | 0.05124673 |
| 125 | RPS6KA6 | 0.04739018 |
| 126 | CSNK1D | 0.04738174 |
| 127 | CAMK2B | 0.04697182 |
| 128 | TNK2 | 0.04334067 |
| 129 | PRKACG | 0.03888657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.36069376 |
| 2 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.01395939 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.70844913 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.52878666 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.35152311 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66149934 |
| 7 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.48726930 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.47872972 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.44245082 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.30240513 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.21124385 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.16836492 |
| 13 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.98623009 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.90558981 |
| 15 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.64800056 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.63617881 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58204997 |
| 18 | Tight junction_Homo sapiens_hsa04530 | 1.56230849 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.56173361 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.53029279 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52051736 |
| 22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46975786 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.46469420 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44174725 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.40761953 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.40707984 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31703740 |
| 28 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.28278868 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23967907 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.21049360 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.18594075 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17266485 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.14808061 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12457447 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07970161 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.05127920 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02245492 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00426579 |
| 39 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.97254558 |
| 40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95299319 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95218988 |
| 42 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93532957 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89972677 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88666477 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88548873 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88212195 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87487565 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.86966217 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86283518 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84928317 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82871216 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81539183 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.77681531 |
| 54 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76443098 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75477524 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75264474 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74451632 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69655242 |
| 59 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.67686278 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65219242 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64704908 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.63988760 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63859236 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62580393 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61815018 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.59915625 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58054040 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56138635 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55816577 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55772007 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55024468 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54422080 |
| 73 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52730412 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.52321887 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50152970 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49888611 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49782954 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48791956 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47751416 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47353678 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46680053 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46260993 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.44472300 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43773705 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41852753 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40917862 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40766816 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.40174220 |
| 89 | Gap junction_Homo sapiens_hsa04540 | 0.38768771 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37038140 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.36141961 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.35197513 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35167262 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34985560 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34501258 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32668433 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32171998 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31772642 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29413864 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26693288 |
| 101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26277783 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25951043 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25258057 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.24742725 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22641679 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.22577535 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20751507 |
| 108 | * Long-term depression_Homo sapiens_hsa04730 | 0.20704600 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20338360 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.19624010 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18905960 |
| 112 | Bile secretion_Homo sapiens_hsa04976 | 0.17882144 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17379191 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.15900767 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15270459 |

